From: Clinical decision support tools: analysis of online drug information databases
Scope Score | n | CP | EP | FC | LC | MM | EF | RL |
---|---|---|---|---|---|---|---|---|
Dosage/Schedule | 17 | 16 | 13 | 14 | 13 | 15 | 12 | 11 |
Drug Interactions | 17 | 14 | 13 | 14 | 13 | 15 | 12 | 12 |
Methods of Administration | 13 | 12 | 12 | 12 | 12 | 13 | 10 | 12 |
Adverse Drug Reactions | 13 | 13 | 9 | 12 | 12 | 13 | 9 | 10 |
Over-the-Counter | 13 | 11 | 4 | 11 | 9 | 6 | 4 | 3 |
Indications/Unlabeled Uses | 11 | 11 | 6 | 8 | 10 | 10 | 6 | 5 |
Identification/Content | 10 | 10 | 7 | 8 | 9 | 8 | 5 | 8 |
Pharmacokinetics | 10 | 8 | 5 | 9 | 8 | 9 | 3 | 6 |
Compatibility/Stability | 9 | 8 | 4 | 6 | 9 | 8 | 1 | 6 |
Contraindications | 9 | 9 | 6 | 8 | 7 | 9 | 5 | 8 |
Dietary Supplements | 8 | 8 | 7 | 8 | 6 | 8 | 0 | 5 |
Pharmacology/MOA | 8 | 8 | 7 | 8 | 8 | 7 | 7 | 8 |
Pregnancy and Lactation | 8 | 7 | 6 | 8 | 8 | 8 | 6 | 8 |
Foreign Drug Identification | 7 | 1 | 0 | 1 | 3 | 3 | 0 | 0 |
Cost and Economics | 5 | 1 | 4 | 1 | 4 | 0 | 4 | 1 |
Totals | 158 | 137 | 103 | 128 | 131 | 132 | 84 | 103 |
(%) | 86.7 | 65.2 | 81.0 | 82.9 | 83.5 | 53.2 | 65.2 |